[Article Metrics] Clinical outcomes following advanced respiratory ...

Clinical outcomes following advanced respiratory motion ... - PubMed

Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body ...

Clinical outcomes following advanced respiratory motion management (respiratory gating or dynamic tumor tracking) with stereotactic body radiation therapy ...

Clinical outcomes following advanced respiratory motion ... - NCBI

To report the outcomes of stereotactic body radiation therapy (SBRT) for stage I non-small-cell lung cancer (NSCLC) according to respiratory ...

Clinical outcomes among patients with advanced non-small cell ...

Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting. Authors: Mo ...

Biomarkers and clinical outcomes after tezepelumab cessation

Long-term tezepelumab treatment in the DESTINATION study (NCT03706079) resulted in reduced asthma exacerbations, reduced biomarker levels, and improved lung ...

Treatment Patterns and Clinical Outcomes in Patients With EGFR ...

For patients with advanced epidermal growth factor receptor (EGFR)-mutated non–small-cell lung cancer (NSCLC) who progress on first-line ...

Clinical Outcomes and Predictors of Lung Toxicity After Multiple ...

The clinical outcomes of multicourse lung stereotactic body radiotherapy (SBRT) have yet to be validated in a prospective study, and there are a lack of data on ...

A community challenge to predict clinical outcomes after immune ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, with advanced non-small cell lung cancer (NSCLC) among the tumor types ...

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in ...

Despite advances in treatments for advanced non–small cell lung cancer (NSCLC), breakthroughs have only recently emerged for early-stage disease ...

Clinical Outcomes of Maintenance Durvalumab After Definitive ...

Article metrics; Related Articles. Abstract. Introduction. The role of maintenance ... advanced non-small cell lung cancer patients treated with EGFR-TKIs.

EP.11A.12 Real-World Treatment Patterns and Clinical Outcomes ...

Effective treatment options for advanced/metastatic non-small cell lung cancer (NSCLC) are limited, especially for those with progression after platinum ...

Treatment patterns and clinical outcomes in patients with advanced ...

Treatments for advanced non-small cell lung cancer (NSCLC) have evolved to include targeted and immuno-oncology therapies, ...

Clinical outcomes of maintenance durvalumab after definitive ...

8061Background: The role of maintenance durvalumab after definitive concurrent chemoradiotherapy (CCRT) in unresectable locally advanced non-small cell lung ...

Clinical Outcomes Following the Implementation of a Novel One ...

Clinical metrics and outcomes used pre-/post-CPEM implementation. Patients at risk for cardiovascular disease/acute coronary syndrome, sepsis, respiratory ...

Clinical Outcomes After Trimodality Therapy With Dose-Escalated ...

... Advanced Non-Small Cell Lung Cancer. K.X. Liu. K.X. Liu. Affiliations ... Article metrics. Metric data currently unavailable. Related Articles. We haven ...

Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for ...

Clinical results of carbon-ion radiotherapy for stage I non-small cell lung ... advanced nonsmall-cell lung cancer outcomes in the real world.

Clinical outcomes following preimplantation genetic testing for ...

∙ Shen, K. Monogenic diseases in respiratory medicine: clinical perspectives ... Article metrics. Metric data currently unavailable. Related articles (40).

Long-Term Clinical, Radiological, and Mortality Outcomes Following ...

Pneumonitis after concurrent chemoradiation and immune checkpoint inhibition in patients with locally advanced non-small cell lung cancer ... Article metrics. 1.

Ten years outcomes after SABR in central and ultracentral primary ...

Both clinical toxicity and fatal lung haemorrhage were most observed when tumors were located ≤ 1 cm from the trachea or main bronchi (46% of ...

Effect of Lymphopenia on Tumor Response and Clinical Outcomes ...

... after CRT would be associated with hematologic metrics and might predict clinical outcomes. ... Advanced Non-Small Cell Lung Carcinoma ...